Close Menu

You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.

Home » Business, Policy & Funding » Business News » Cepheid, Sherlock Biosciences Partner on SARS-CoV-2 Diagnostic Test

Cepheid, Sherlock Biosciences Partner on SARS-CoV-2 Diagnostic Test

Feb 28, 2020
|
staff reporter

NEW YORK – Cepheid and Sherlock Biosciences said on Friday that they have formed a research collaboration to develop new molecular diagnostic tests, using Sherlock Biosciences' CRISPR-based engineering biology platform SHERLOCK to design tests to run on Cepheid's GeneXpert systems.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Scan

See the Picture

Researchers in India plan to sequence SARS-CoV-2 isolates from around the country, according to LiveMint.

Top EU Scientist Resigns

Mauro Ferrari has resigned as president of the European Research Council over its response to the COVID-19 pandemic, the Financial Times reports.

Cuts at Some Health Tech Startups

Stat News reports some health tech startups are laying off or furloughing workers.

Genome Research Papers on Microsatellite Indels in Cancer, Gene Regulation Analyses

In Genome Research this week: indels affecting microsatellites in cancer, analytical approach to find key regulatory elements, and more.

What's Popular?

In Business News

  1. FDA Issues Emergency Use Authorization for Viracor Eurofins Coronavirus LDT

  2. COVID-19 Testing Drives 80 Percent Growth in GenMark Diagnostics Preliminary Q1 Revenues

  3. Pacific Biosciences Shares Spike on SARS-CoV-2 Research Initiatives

  4. FDA Issues Emergency Use Authorization for Gnomegen Coronavirus Test

  5. Coronavirus Pandemic Expected to Significantly Disrupt Hologic Q2 Revenues

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2020 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.